|
531 |
Future Perspective of Artificial Intelligence Diagnostics for Early Barrett’s Neoplasia
Enthalten in Digestion Bd. 107, 2026, Nr. 1: 91-102. 12 S.
|
|
|
|
532 |
Epidemiology of Barrett’s Neoplasia in Japan
Enthalten in Digestion Bd. 107, 2026, Nr. 1: 5-14. 10 S.
|
|
|
|
533 |
A Systematic Review of the Safety of Sedation during Flexible Bronchoscopy
Enthalten in Respiration Bd. 105, 2026, Nr. 1: 37-56. 20 S.
|
|
|
|
534 |
Benralizumab-Induced Asthma Remission: Impact of Different Tools and Thresholds to Define Good Asthma Control
Enthalten in Respiration Bd. 105, 2026, Nr. 1: 12-21. 10 S.
|
|
|
|
535 |
Modified Glasgow Prognostic Score as a Marker for Predicting Outcomes in Patients with either Bladder or Prostate Cancer: A Systematic Review and Meta-Analysis
Enthalten in Oncology Bd. 104, 2026, Nr. 2: 212-225. 14 S.
|
|
|
|
536 |
Patient-Reported Outcome-Based Symptom Management Improves Quality of Life in Postoperative Gastroesophageal Cancer Patients: A Randomized Controlled Trial
Enthalten in Oncology Bd. 104, 2026, Nr. 2: 201-211. 11 S.
|
|
|
|
537 |
Impact of Social Vulnerability Index on Multiple Myeloma Mortality
Enthalten in Oncology Bd. 104, 2026, Nr. 2: 176-180. 5 S.
|
|
|
|
538 |
Determining the Cut-Off Value of the MASCC Score to Predict Mortality in Hospitalized Febrile Neutropenic Patients: A Decade-Long Single-Center Retrospective Cohort Study
Enthalten in Oncology Bd. 104, 2026, Nr. 2: 167-175. 9 S.
|
|
|
|
539 |
Antihistamines Improve the Survival of Lung Cancer: A 10-Year Cohort Study of Tertiary Hospital in Taiwan
Enthalten in Oncology Bd. 104, 2026, Nr. 2: 103-112. 10 S.
|
|
|
|
540 |
The Current Status of Tumor Markers as Biomarkers in the Era of Immunotherapy for Hepatocellular Carcinoma: Alpha-Fetoprotein Alone Is Not Sufficient
Enthalten in Oncology Bd. 104, 2026, Nr. 1: 79-91. 13 S.
|
|
Administration
